Work

A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.52

Authors: Yelena Yuriy Janjigian, Marinela Capanu, Tooba Imtiaz, David Paul Kelsen, Geoffrey Yuyat Ku, Mark Schattner, Karen T. Brown, David H. Ilson, David B. Solit, Michael F. Berger, Efsevia Vakiani

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4231494503

Cites:

Cited by: 11

Related to: 10